Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $97,310 - $115,228
1,421 Added 4.45%
33,349 $2.4 Million
Q3 2022

Oct 20, 2022

BUY
$0.13 - $76.84 $134 - $79,759
1,038 Added 3.36%
31,928 $2.27 Million
Q2 2022

Jul 26, 2022

BUY
$72.62 - $79.98 $452,640 - $498,515
6,233 Added 25.28%
30,890 $2.38 Million
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $705,790 - $846,305
11,480 Added 87.12%
24,657 $1.8 Million
Q4 2021

Jan 28, 2022

BUY
$53.63 - $62.52 $126,405 - $147,359
2,357 Added 21.78%
13,177 $822,000
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $88,340 - $103,479
1,493 Added 16.01%
10,820 $640,000
Q2 2021

Aug 03, 2021

SELL
$61.91 - $67.42 $196,316 - $213,788
-3,171 Reduced 25.37%
9,327 $623,000
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $829,098 - $932,491
-13,972 Reduced 52.78%
12,498 $789,000
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $22,056 - $24,994
-382 Reduced 1.42%
26,470 $1.64 Million
Q3 2020

Nov 04, 2020

BUY
$57.43 - $63.64 $66,848 - $74,076
1,164 Added 4.53%
26,852 $1.62 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $10,415 - $12,177
190 Added 0.75%
25,688 $1.51 Million
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $64,078 - $93,120
-1,381 Reduced 5.14%
25,498 $1.42 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $840,949 - $1.1 Million
17,089 Added 174.56%
26,879 $1.78 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $160,216 - $189,959
3,746 Added 61.98%
9,790 $496,000
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $70,811 - $78,302
1,587 Added 35.61%
6,044 $274,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $17,732 - $21,143
-393 Reduced 8.1%
4,457 $213,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $4,973 - $6,449
102 Added 2.15%
4,850 $252,000
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $27,815 - $31,374
-504 Reduced 9.6%
4,748 $295,000
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $8,286 - $10,328
-164 Reduced 3.03%
5,252 $0
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $10,006 - $11,519
167 Added 3.18%
5,416 $343,000
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $2,817 - $3,071
-47 Reduced 0.89%
5,249 $322,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $22,644 - $26,133
410 Added 8.39%
5,296 $338,000
Q2 2017

Aug 08, 2017

BUY
N/A
4,886
4,886 $272,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Argi Investment Services, LLC Portfolio

Follow Argi Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argi Investment Services, LLC with notifications on news.